NSECertificate under SEBI (Depositories and Participants) Regulations, 20185 Oct 2026 · 5 Oct 2026, 07:03 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI Summary
Jubilant Pharmova Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and substitution of the depository's name as the registered owner.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
JUBLPHARMA_05102026190249_IntimationReg745signedQ2F.pdf
View document text
October 05, 2026
BSE Limited National Stock Exchange of India Limited
Floor 25, P. J. Towers Exchange Plaza
Dalal Street, Fort Bandra Kurla Complex
Mumbai - 400 001 Bandra (E)
Mumbai - 400 051
Scrip Code: 530019 Symbol: JUBLPHARMA
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018
Dear Sir/Madam,
In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are
enclosing a confirmation Certificate for the quarter ended on September 30, 2026 received from M/s
Alankit Assignments Limited, Registrar and Share Transfer Agent of the Company.
We request you to take the same on record.
Thanking you,
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Encl: as above
National Securities Depository Limited Trade Central Depository Services (India) Limited
World, A wing, 4th Floor, Kamala Mills Marathon Futurex, A-Wing, 25th Floor,
Compound, Lower Parel, NM Joshi Marg, Lower Parel,
Mumbai-400013 Mumbai-400013
5th October, 2026
The Company Secretary
Jubilant Pharmova Limited
1A, Sector 16A
NOIDA- 201301, U.P.
Subject: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018 for the quarter ended September, 30, 2026.
Dear Sir,
In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018 for the quarter ended September, 30, 2026, w.r.t. physical share certificates or Letter of
Confirmation received for dematerialization of securities (Equity Shares) of the Company i.e.
“Jubilant Pharmova Limited”, we hereby confirm and certify the following:
a) The securities comprised in the said certificate(s) have been listed on the Stock Exchanges;
b) The said certificate(s) after due verification have been mutilated and cancelled and the name
of depository has been substituted in our record as registered owner.
This is for your information and record.
Thanking You,
For ALANKIT ASSIGNMENTS LIMITED
K GA AM RGAL DD26sHptsacDit e n5.2 tsoiN a5 r lrg e c=3e e tu i.:4 8ai u e 0e K=tc s l. 9 :da et Ai2 N = 2n= 27l 8 o0l 9 MI u 0gy bSN 1 n= 1m 2 o aAbs, yB 77 6 2is 7 m LbSo ,g c . t 5 16u5 ea=n G= e 022 br reH A3ed = .d2 h 0d 4a f R 7ae bC 5a r eGb 184y s eo b 13cy h7 a al 2bf o a7 n 1K fC :394 nd 4a 3A h 7a4 y 6,5 9 M a 835 :7 dJ 4n 15fA h6 5 97d d41 aL 0 6e e0 +e r 4aG sr 8f 0b 4 5 5a 21A 5c e6 c f6RR '7 81 90 33obG 94 3e 0 a6 M 78 f, ' 7dbp 38I 1 3 G b3o S 2c as e c 136t 8 eca ,rb t8 8 d ol oC 31 a =rf ba3o l P1o 4e 6d e5dod 9e r r 7 0b G= s 4 8of1 ue 8 4n2 rb 6 3g a20 4 ela0 ,8 8 b o05 , dn1 ,,
Kamal Garg
(General Manager)